Concepts (291)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Ixodes | 21 | 2025 | 34 | 9.480 |
Why?
|
| Borrelia burgdorferi | 9 | 2024 | 90 | 3.390 |
Why?
|
| Tick Bites | 4 | 2025 | 10 | 2.900 |
Why?
|
| Ixodidae | 4 | 2025 | 5 | 2.900 |
Why?
|
| Lyme Disease | 9 | 2024 | 122 | 2.590 |
Why?
|
| Deer | 10 | 2024 | 12 | 2.530 |
Why?
|
| Borrelia | 6 | 2022 | 32 | 2.390 |
Why?
|
| Arachnid Vectors | 5 | 2025 | 9 | 1.980 |
Why?
|
| Ticks | 10 | 2024 | 35 | 1.960 |
Why?
|
| Malaria | 7 | 2014 | 148 | 1.780 |
Why?
|
| Encephalitis Viruses, Tick-Borne | 2 | 2024 | 6 | 1.750 |
Why?
|
| Insect Repellents | 2 | 2025 | 3 | 1.740 |
Why?
|
| Tick-Borne Diseases | 3 | 2023 | 7 | 1.570 |
Why?
|
| Animals | 63 | 2025 | 20634 | 1.530 |
Why?
|
| Phylogeny | 14 | 2025 | 376 | 1.470 |
Why?
|
| Artemisia annua | 3 | 2015 | 7 | 1.300 |
Why?
|
| Genetic Variation | 7 | 2020 | 383 | 1.270 |
Why?
|
| Plasmodium falciparum | 9 | 2009 | 246 | 1.260 |
Why?
|
| Anaplasma phagocytophilum | 3 | 2022 | 9 | 1.250 |
Why?
|
| Genotype | 6 | 2025 | 664 | 1.130 |
Why?
|
| Plasmodium | 6 | 2009 | 33 | 1.120 |
Why?
|
| Coleoptera | 2 | 2017 | 5 | 1.030 |
Why?
|
| Dermacentor | 3 | 2022 | 3 | 0.980 |
Why?
|
| Artemisinins | 3 | 2015 | 38 | 0.970 |
Why?
|
| Rickettsia | 1 | 2025 | 2 | 0.940 |
Why?
|
| Aldehydes | 1 | 2025 | 16 | 0.940 |
Why?
|
| Pheromones | 1 | 2025 | 21 | 0.930 |
Why?
|
| Borrelia Infections | 3 | 2021 | 12 | 0.930 |
Why?
|
| Real-Time Polymerase Chain Reaction | 3 | 2024 | 207 | 0.920 |
Why?
|
| Antimalarials | 3 | 2015 | 124 | 0.910 |
Why?
|
| Borrelia burgdorferi Group | 3 | 2023 | 30 | 0.860 |
Why?
|
| Evolution, Molecular | 7 | 2011 | 322 | 0.820 |
Why?
|
| Nymph | 5 | 2025 | 7 | 0.820 |
Why?
|
| Ehrlichia | 2 | 2023 | 3 | 0.800 |
Why?
|
| Zoonoses | 1 | 2020 | 9 | 0.680 |
Why?
|
| Ehrlichiosis | 2 | 2018 | 6 | 0.670 |
Why?
|
| Cycas | 2 | 2017 | 2 | 0.620 |
Why?
|
| Trypanosomatina | 1 | 2017 | 1 | 0.570 |
Why?
|
| Crithidia | 1 | 2017 | 2 | 0.570 |
Why?
|
| Bees | 1 | 2017 | 5 | 0.570 |
Why?
|
| Multiplex Polymerase Chain Reaction | 1 | 2017 | 15 | 0.570 |
Why?
|
| Larva | 4 | 2025 | 139 | 0.570 |
Why?
|
| Relapsing Fever | 2 | 2016 | 17 | 0.570 |
Why?
|
| Culicidae | 3 | 2013 | 12 | 0.560 |
Why?
|
| Plant Leaves | 2 | 2014 | 39 | 0.540 |
Why?
|
| Massachusetts | 5 | 2023 | 2075 | 0.530 |
Why?
|
| Babesia microti | 2 | 2023 | 7 | 0.520 |
Why?
|
| Humans | 37 | 2025 | 63283 | 0.500 |
Why?
|
| Insect Vectors | 2 | 2013 | 15 | 0.500 |
Why?
|
| Polymorphism, Genetic | 7 | 2001 | 191 | 0.470 |
Why?
|
| Feeding Methods | 1 | 2014 | 9 | 0.450 |
Why?
|
| Silicones | 1 | 2014 | 14 | 0.450 |
Why?
|
| Molecular Sequence Data | 17 | 2013 | 1990 | 0.440 |
Why?
|
| Antigens, Bacterial | 3 | 2022 | 199 | 0.440 |
Why?
|
| Membranes, Artificial | 1 | 2014 | 45 | 0.440 |
Why?
|
| Drug Resistance | 1 | 2015 | 149 | 0.430 |
Why?
|
| RNA, Ribosomal, 16S | 5 | 2017 | 87 | 0.400 |
Why?
|
| Parasitemia | 1 | 2012 | 47 | 0.400 |
Why?
|
| Tick Infestations | 1 | 2012 | 2 | 0.400 |
Why?
|
| Primate Diseases | 1 | 2012 | 2 | 0.400 |
Why?
|
| Cheirogaleidae | 1 | 2012 | 6 | 0.400 |
Why?
|
| Plants, Medicinal | 1 | 2012 | 61 | 0.390 |
Why?
|
| Epidemiological Monitoring | 2 | 2024 | 31 | 0.390 |
Why?
|
| Gene Frequency | 2 | 2012 | 123 | 0.370 |
Why?
|
| Female | 18 | 2025 | 32776 | 0.370 |
Why?
|
| Seasons | 3 | 2018 | 134 | 0.370 |
Why?
|
| Merozoite Surface Protein 1 | 5 | 2003 | 24 | 0.360 |
Why?
|
| Parasites | 1 | 2011 | 16 | 0.360 |
Why?
|
| Base Sequence | 13 | 2012 | 1329 | 0.350 |
Why?
|
| Antigens, Protozoan | 3 | 2000 | 56 | 0.340 |
Why?
|
| Bacteria | 1 | 2013 | 304 | 0.330 |
Why?
|
| Protozoan Proteins | 5 | 2009 | 126 | 0.320 |
Why?
|
| Species Specificity | 5 | 2016 | 334 | 0.310 |
Why?
|
| DNA, Protozoan | 6 | 2003 | 50 | 0.310 |
Why?
|
| Genetics, Population | 4 | 2024 | 44 | 0.290 |
Why?
|
| Male | 12 | 2025 | 29799 | 0.280 |
Why?
|
| Animal Distribution | 2 | 2018 | 4 | 0.280 |
Why?
|
| Bacterial Outer Membrane Proteins | 2 | 2022 | 121 | 0.270 |
Why?
|
| Polymerase Chain Reaction | 9 | 2013 | 517 | 0.270 |
Why?
|
| DNA, Ribosomal | 2 | 1997 | 31 | 0.260 |
Why?
|
| Maine | 2 | 2025 | 18 | 0.240 |
Why?
|
| DEET | 1 | 2025 | 1 | 0.240 |
Why?
|
| Multilocus Sequence Typing | 1 | 2025 | 5 | 0.240 |
Why?
|
| Peromyscus | 2 | 2023 | 4 | 0.230 |
Why?
|
| Cryptosporidium parvum | 5 | 2003 | 8 | 0.230 |
Why?
|
| Genes, Protozoan | 3 | 2000 | 14 | 0.230 |
Why?
|
| DNA Primers | 4 | 2022 | 291 | 0.230 |
Why?
|
| Gene Flow | 1 | 2024 | 6 | 0.230 |
Why?
|
| Population Dynamics | 1 | 2024 | 19 | 0.220 |
Why?
|
| Encephalitis, Tick-Borne | 1 | 2024 | 5 | 0.220 |
Why?
|
| Plasmodium vivax | 1 | 2004 | 46 | 0.220 |
Why?
|
| DNA, Mitochondrial | 3 | 2020 | 87 | 0.220 |
Why?
|
| Watchful Waiting | 1 | 2024 | 29 | 0.210 |
Why?
|
| Haplotypes | 2 | 2020 | 131 | 0.210 |
Why?
|
| Biological Evolution | 2 | 2004 | 122 | 0.210 |
Why?
|
| Dog Diseases | 1 | 2024 | 60 | 0.210 |
Why?
|
| Plasmodium chabaudi | 2 | 2014 | 29 | 0.210 |
Why?
|
| Anaplasma | 1 | 2023 | 1 | 0.210 |
Why?
|
| Geography | 3 | 2020 | 38 | 0.210 |
Why?
|
| Sequence Alignment | 3 | 2012 | 300 | 0.200 |
Why?
|
| Dogs | 2 | 2024 | 325 | 0.200 |
Why?
|
| Rodentia | 1 | 2023 | 22 | 0.200 |
Why?
|
| Amino Acid Sequence | 6 | 2009 | 1592 | 0.200 |
Why?
|
| Child, Preschool | 3 | 2018 | 1988 | 0.200 |
Why?
|
| Washington | 2 | 2020 | 26 | 0.190 |
Why?
|
| Antibodies, Viral | 1 | 2024 | 325 | 0.190 |
Why?
|
| Technology | 1 | 2022 | 52 | 0.190 |
Why?
|
| Phlebovirus | 1 | 2021 | 2 | 0.190 |
Why?
|
| Regression Analysis | 1 | 2023 | 498 | 0.190 |
Why?
|
| Alleles | 2 | 2003 | 447 | 0.180 |
Why?
|
| Cattle Diseases | 1 | 2001 | 10 | 0.180 |
Why?
|
| Asia | 2 | 2017 | 25 | 0.170 |
Why?
|
| Crowdsourcing | 1 | 2020 | 15 | 0.170 |
Why?
|
| Photography | 1 | 2020 | 41 | 0.170 |
Why?
|
| Polymorphism, Single Nucleotide | 3 | 2017 | 491 | 0.170 |
Why?
|
| RNA | 1 | 2024 | 423 | 0.170 |
Why?
|
| Coinfection | 1 | 2020 | 58 | 0.170 |
Why?
|
| Bayes Theorem | 1 | 2020 | 122 | 0.160 |
Why?
|
| Cryptosporidiosis | 5 | 2003 | 10 | 0.160 |
Why?
|
| Biomedical Research | 1 | 2003 | 268 | 0.160 |
Why?
|
| United States | 4 | 2021 | 7828 | 0.160 |
Why?
|
| Cattle | 3 | 2014 | 308 | 0.160 |
Why?
|
| Sequence Analysis, DNA | 4 | 2013 | 413 | 0.150 |
Why?
|
| Oregon | 1 | 2018 | 19 | 0.150 |
Why?
|
| New York | 3 | 2024 | 144 | 0.150 |
Why?
|
| California | 1 | 2018 | 174 | 0.140 |
Why?
|
| DNA, Bacterial | 3 | 2013 | 265 | 0.140 |
Why?
|
| Genes, Bacterial | 1 | 2018 | 118 | 0.140 |
Why?
|
| New England | 1 | 2018 | 273 | 0.140 |
Why?
|
| Epitopes | 1 | 1998 | 289 | 0.140 |
Why?
|
| Genetic Heterogeneity | 1 | 1997 | 21 | 0.140 |
Why?
|
| History, 21st Century | 1 | 2018 | 171 | 0.140 |
Why?
|
| Lipoproteins | 1 | 2017 | 83 | 0.130 |
Why?
|
| Adult | 5 | 2024 | 16771 | 0.130 |
Why?
|
| Recombination, Genetic | 4 | 2003 | 246 | 0.130 |
Why?
|
| Pollen | 1 | 2015 | 5 | 0.120 |
Why?
|
| Middle Aged | 3 | 2024 | 17535 | 0.120 |
Why?
|
| Malaria, Falciparum | 1 | 1998 | 220 | 0.120 |
Why?
|
| Atherosclerosis | 1 | 2017 | 153 | 0.120 |
Why?
|
| Malaria Vaccines | 2 | 2007 | 37 | 0.120 |
Why?
|
| Prevalence | 2 | 2018 | 1377 | 0.120 |
Why?
|
| Epistasis, Genetic | 1 | 2015 | 42 | 0.120 |
Why?
|
| Child | 3 | 2018 | 4522 | 0.120 |
Why?
|
| China | 1 | 2015 | 164 | 0.110 |
Why?
|
| Infant | 2 | 2018 | 1649 | 0.110 |
Why?
|
| Genetic Loci | 1 | 2015 | 115 | 0.110 |
Why?
|
| Arthropod Vectors | 1 | 2014 | 3 | 0.110 |
Why?
|
| Mice | 9 | 2015 | 10827 | 0.110 |
Why?
|
| Behavior, Animal | 1 | 2016 | 230 | 0.110 |
Why?
|
| Pneumonia | 1 | 2016 | 290 | 0.110 |
Why?
|
| Denaturing Gradient Gel Electrophoresis | 1 | 2013 | 1 | 0.110 |
Why?
|
| DNA | 3 | 2012 | 832 | 0.100 |
Why?
|
| Rhode Island | 1 | 2013 | 98 | 0.100 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 3 | 2002 | 81 | 0.100 |
Why?
|
| Administration, Oral | 1 | 2014 | 369 | 0.100 |
Why?
|
| Genome, Protozoan | 2 | 2004 | 13 | 0.100 |
Why?
|
| Madagascar | 1 | 2012 | 4 | 0.100 |
Why?
|
| Hemolytic-Uremic Syndrome | 2 | 2002 | 7 | 0.100 |
Why?
|
| Antibodies, Bacterial | 3 | 2002 | 181 | 0.100 |
Why?
|
| Microbiota | 1 | 2013 | 128 | 0.090 |
Why?
|
| Body Mass Index | 1 | 2015 | 863 | 0.090 |
Why?
|
| Mutation | 3 | 2009 | 2607 | 0.090 |
Why?
|
| Aged | 2 | 2024 | 14384 | 0.080 |
Why?
|
| Time Factors | 2 | 2016 | 3757 | 0.080 |
Why?
|
| RNA Viruses | 1 | 2009 | 10 | 0.080 |
Why?
|
| Protozoan Infections, Animal | 1 | 2009 | 2 | 0.080 |
Why?
|
| Pan troglodytes | 1 | 2009 | 32 | 0.080 |
Why?
|
| Biosurveillance | 1 | 2009 | 3 | 0.080 |
Why?
|
| Babesiosis | 1 | 2009 | 12 | 0.080 |
Why?
|
| New Hampshire | 1 | 2009 | 43 | 0.080 |
Why?
|
| Ecosystem | 1 | 2009 | 53 | 0.080 |
Why?
|
| Communicable Diseases, Emerging | 1 | 2009 | 21 | 0.080 |
Why?
|
| N-Acetylneuraminic Acid | 1 | 2009 | 48 | 0.080 |
Why?
|
| Adolescent | 2 | 2018 | 6238 | 0.070 |
Why?
|
| Young Adult | 1 | 2018 | 4683 | 0.070 |
Why?
|
| Glycoproteins | 1 | 2009 | 187 | 0.070 |
Why?
|
| Likelihood Functions | 1 | 2007 | 69 | 0.070 |
Why?
|
| Escherichia coli | 3 | 2004 | 700 | 0.070 |
Why?
|
| Microsatellite Repeats | 3 | 2003 | 41 | 0.070 |
Why?
|
| Obesity | 1 | 2015 | 1230 | 0.070 |
Why?
|
| Mice, Inbred C57BL | 1 | 2014 | 3391 | 0.060 |
Why?
|
| Demography | 2 | 1998 | 173 | 0.060 |
Why?
|
| Linkage Disequilibrium | 2 | 2003 | 47 | 0.060 |
Why?
|
| Diarrhea | 2 | 2003 | 76 | 0.060 |
Why?
|
| Immunization, Passive | 2 | 2002 | 105 | 0.060 |
Why?
|
| Population Surveillance | 2 | 2020 | 206 | 0.060 |
Why?
|
| Haplorhini | 1 | 2004 | 14 | 0.060 |
Why?
|
| RNA, Bacterial | 2 | 2004 | 74 | 0.060 |
Why?
|
| Sequence Homology, Nucleic Acid | 2 | 2002 | 112 | 0.060 |
Why?
|
| Malaria, Vivax | 1 | 2004 | 48 | 0.050 |
Why?
|
| Germ-Free Life | 2 | 2002 | 8 | 0.050 |
Why?
|
| Histidine | 1 | 2004 | 34 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 2003 | 10 | 0.050 |
Why?
|
| Maryland | 2 | 2020 | 35 | 0.050 |
Why?
|
| Thogotovirus | 1 | 2023 | 1 | 0.050 |
Why?
|
| Tanzania | 1 | 2003 | 37 | 0.050 |
Why?
|
| Shiga Toxin 1 | 1 | 2002 | 2 | 0.050 |
Why?
|
| Thailand | 1 | 2003 | 98 | 0.050 |
Why?
|
| Brazil | 1 | 2003 | 100 | 0.050 |
Why?
|
| Swine | 2 | 2002 | 374 | 0.050 |
Why?
|
| Staphylococcus aureus | 1 | 2004 | 176 | 0.050 |
Why?
|
| Giardia lamblia | 1 | 2002 | 1 | 0.050 |
Why?
|
| Vietnam | 1 | 2003 | 173 | 0.050 |
Why?
|
| Long Interspersed Nucleotide Elements | 1 | 2002 | 18 | 0.050 |
Why?
|
| Immunoglobulin kappa-Chains | 1 | 2002 | 9 | 0.050 |
Why?
|
| Shiga Toxin 2 | 1 | 2002 | 3 | 0.050 |
Why?
|
| Escherichia coli O157 | 1 | 2002 | 20 | 0.050 |
Why?
|
| Opportunistic Infections | 1 | 2002 | 30 | 0.050 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 2004 | 363 | 0.050 |
Why?
|
| Genomics | 1 | 2004 | 370 | 0.040 |
Why?
|
| Flagellin | 1 | 2001 | 14 | 0.040 |
Why?
|
| Sequence Homology | 1 | 2000 | 20 | 0.040 |
Why?
|
| Antibodies, Monoclonal | 2 | 2002 | 863 | 0.040 |
Why?
|
| RNA, Ribosomal | 1 | 2000 | 56 | 0.040 |
Why?
|
| Genome | 1 | 2003 | 276 | 0.040 |
Why?
|
| Interferon-gamma | 1 | 2002 | 566 | 0.040 |
Why?
|
| Hominidae | 1 | 1999 | 7 | 0.040 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2003 | 718 | 0.040 |
Why?
|
| Asthma | 1 | 2003 | 440 | 0.040 |
Why?
|
| Climate | 1 | 1998 | 4 | 0.040 |
Why?
|
| South America | 1 | 1998 | 26 | 0.040 |
Why?
|
| Netherlands | 1 | 1998 | 24 | 0.040 |
Why?
|
| Africa | 1 | 1998 | 27 | 0.040 |
Why?
|
| Tetrahydrofolate Dehydrogenase | 1 | 1998 | 22 | 0.040 |
Why?
|
| Life Cycle Stages | 1 | 1998 | 17 | 0.040 |
Why?
|
| Time | 1 | 1998 | 30 | 0.040 |
Why?
|
| Case-Control Studies | 2 | 2015 | 1121 | 0.030 |
Why?
|
| Mice, Knockout | 4 | 2002 | 2107 | 0.030 |
Why?
|
| Hospitalization | 1 | 2003 | 1355 | 0.030 |
Why?
|
| Population | 1 | 1995 | 13 | 0.030 |
Why?
|
| Diet, Western | 1 | 2015 | 8 | 0.030 |
Why?
|
| DNA Helicases | 1 | 1996 | 190 | 0.030 |
Why?
|
| Trans-Activators | 1 | 1996 | 314 | 0.030 |
Why?
|
| Repressor Proteins | 1 | 1996 | 347 | 0.030 |
Why?
|
| Disease Reservoirs | 1 | 1993 | 10 | 0.030 |
Why?
|
| Escherichia coli Proteins | 1 | 1996 | 269 | 0.030 |
Why?
|
| Genome-Wide Association Study | 1 | 2015 | 359 | 0.030 |
Why?
|
| RNA-Binding Proteins | 1 | 1996 | 434 | 0.020 |
Why?
|
| Neutralization Tests | 2 | 2002 | 122 | 0.020 |
Why?
|
| Polymorphism, Restriction Fragment Length | 2 | 2003 | 26 | 0.020 |
Why?
|
| Mitochondria | 1 | 1995 | 371 | 0.020 |
Why?
|
| HeLa Cells | 2 | 2002 | 535 | 0.020 |
Why?
|
| Proteins | 1 | 1996 | 751 | 0.020 |
Why?
|
| Bacterial Proteins | 1 | 1996 | 766 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 1996 | 894 | 0.020 |
Why?
|
| Immunoglobulin G | 2 | 2002 | 459 | 0.020 |
Why?
|
| Tropical Climate | 1 | 2009 | 2 | 0.020 |
Why?
|
| Africa, Western | 1 | 2009 | 5 | 0.020 |
Why?
|
| Trees | 1 | 2009 | 3 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 1996 | 1184 | 0.020 |
Why?
|
| Plasmids | 2 | 2004 | 291 | 0.020 |
Why?
|
| Rats | 1 | 1993 | 1977 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2017 | 5443 | 0.020 |
Why?
|
| Disease Vectors | 2 | 1996 | 7 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 2004 | 150 | 0.010 |
Why?
|
| RNA, Antisense | 1 | 2004 | 51 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2004 | 182 | 0.010 |
Why?
|
| Diarrhea, Infantile | 1 | 2003 | 3 | 0.010 |
Why?
|
| Nutrition Disorders | 1 | 2003 | 7 | 0.010 |
Why?
|
| Mutagenesis | 1 | 2004 | 132 | 0.010 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2004 | 247 | 0.010 |
Why?
|
| Uganda | 1 | 2003 | 56 | 0.010 |
Why?
|
| Cell Communication | 1 | 2004 | 130 | 0.010 |
Why?
|
| Hybridomas | 1 | 2002 | 63 | 0.010 |
Why?
|
| Immunoglobulin M | 1 | 2002 | 115 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2004 | 671 | 0.010 |
Why?
|
| Chromosome Mapping | 1 | 2003 | 289 | 0.010 |
Why?
|
| Open Reading Frames | 1 | 2002 | 84 | 0.010 |
Why?
|
| Immunoglobulin Isotypes | 1 | 2002 | 24 | 0.010 |
Why?
|
| Telomere | 1 | 2002 | 52 | 0.010 |
Why?
|
| Crosses, Genetic | 1 | 2002 | 110 | 0.010 |
Why?
|
| Antibody Specificity | 1 | 2002 | 102 | 0.010 |
Why?
|
| In Vitro Techniques | 1 | 2002 | 488 | 0.010 |
Why?
|
| Disease Susceptibility | 1 | 2002 | 165 | 0.010 |
Why?
|
| Conserved Sequence | 1 | 2002 | 174 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2004 | 937 | 0.010 |
Why?
|
| Karyotyping | 1 | 2000 | 48 | 0.010 |
Why?
|
| Body Weight | 1 | 2002 | 377 | 0.010 |
Why?
|
| Phenotype | 1 | 2004 | 1200 | 0.010 |
Why?
|
| Survival Rate | 1 | 2002 | 850 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2003 | 1355 | 0.010 |
Why?
|
| Mosaicism | 1 | 1996 | 30 | 0.010 |
Why?
|
| Nucleic Acid Hybridization | 1 | 1996 | 98 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2003 | 2569 | 0.010 |
Why?
|
| Genes | 1 | 1995 | 90 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2002 | 2180 | 0.010 |
Why?
|
| Animals, Domestic | 1 | 1993 | 15 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2004 | 3033 | 0.010 |
Why?
|
| Cats | 1 | 1993 | 87 | 0.010 |
Why?
|
| Host-Parasite Interactions | 1 | 1993 | 58 | 0.010 |
Why?
|
| Incidence | 1 | 1993 | 1375 | 0.000 |
Why?
|